Trials / Terminated
TerminatedNCT01144754
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
A Prospective Observational Study of Newly Diagnosed Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP With or Without Radiotherapy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center observational study to assess addition of Rituximab in the treatment of previously untreated patients with Diffuse Large B-Cell Lymphomas(DLBCL) over an enrollment period of 60 months. Patients in this study are enrolling for the collection of their data on observations made during normal clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rituximab | Calculated per patient |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2010-06-16
- Last updated
- 2016-07-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01144754. Inclusion in this directory is not an endorsement.